nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—SLC28A3—prostate gland—prostate cancer	0.0163	0.1	CbGeAlD
Fludarabine—POLA1—prostate gland—prostate cancer	0.0115	0.0705	CbGeAlD
Fludarabine—POLA1—seminal vesicle—prostate cancer	0.0097	0.0597	CbGeAlD
Fludarabine—RRM1—prostate gland—prostate cancer	0.0091	0.056	CbGeAlD
Fludarabine—SLC28A3—bone marrow—prostate cancer	0.00841	0.0517	CbGeAlD
Fludarabine—RRM1—seminal vesicle—prostate cancer	0.0077	0.0474	CbGeAlD
Fludarabine—POLA1—urethra—prostate cancer	0.00768	0.0472	CbGeAlD
Fludarabine—SLC29A1—prostate gland—prostate cancer	0.0074	0.0455	CbGeAlD
Fludarabine—DCK—prostate gland—prostate cancer	0.00707	0.0435	CbGeAlD
Fludarabine—RRM1—renal system—prostate cancer	0.0062	0.0382	CbGeAlD
Fludarabine—RRM1—urethra—prostate cancer	0.00609	0.0375	CbGeAlD
Fludarabine—DCK—seminal vesicle—prostate cancer	0.00598	0.0368	CbGeAlD
Fludarabine—POLA1—bone marrow—prostate cancer	0.00591	0.0364	CbGeAlD
Fludarabine—POLA1—testis—prostate cancer	0.00505	0.0311	CbGeAlD
Fludarabine—SLC29A1—renal system—prostate cancer	0.00504	0.031	CbGeAlD
Fludarabine—SLC29A1—urethra—prostate cancer	0.00496	0.0305	CbGeAlD
Fludarabine—DCK—urethra—prostate cancer	0.00473	0.0291	CbGeAlD
Fludarabine—RRM1—bone marrow—prostate cancer	0.00469	0.0289	CbGeAlD
Fludarabine—RRM1—testis—prostate cancer	0.00401	0.0247	CbGeAlD
Fludarabine—SLC29A1—bone marrow—prostate cancer	0.00381	0.0235	CbGeAlD
Fludarabine—S-Adenosylmethionine—GNMT—prostate cancer	0.00368	0.252	CrCbGaD
Fludarabine—POLA1—lymph node—prostate cancer	0.00366	0.0225	CbGeAlD
Fludarabine—DCK—bone marrow—prostate cancer	0.00364	0.0224	CbGeAlD
Fludarabine—SLC29A1—testis—prostate cancer	0.00326	0.0201	CbGeAlD
Fludarabine—DCK—testis—prostate cancer	0.00311	0.0192	CbGeAlD
Fludarabine—RRM1—Fulvestrant—Estradiol—prostate cancer	0.00303	0.24	CbGdCrCtD
Fludarabine—RRM1—lymph node—prostate cancer	0.00291	0.0179	CbGeAlD
Fludarabine—SLC29A1—lymph node—prostate cancer	0.00236	0.0145	CbGeAlD
Fludarabine—Azacitidine—DNMT1—prostate cancer	0.00234	0.16	CrCbGaD
Fludarabine—DCK—lymph node—prostate cancer	0.00226	0.0139	CbGeAlD
Fludarabine—Adenosine triphosphate—HSPA1A—prostate cancer	0.00208	0.142	CrCbGaD
Fludarabine—DCK—Estradiol valerate/Dienogest—Estrone—prostate cancer	0.00133	0.106	CbGdCrCtD
Fludarabine—Flavin adenine dinucleotide—NQO1—prostate cancer	0.00119	0.0817	CrCbGaD
Fludarabine—DCK—Fulvestrant—Estradiol—prostate cancer	0.00108	0.0854	CbGdCrCtD
Fludarabine—POLA1—Norethindrone—Ethinyl Estradiol—prostate cancer	0.00103	0.0815	CbGdCrCtD
Fludarabine—DCK—Estradiol valerate/Dienogest—Estradiol—prostate cancer	0.00101	0.08	CbGdCrCtD
Fludarabine—DCK—Estradiol valerate/Dienogest—Ethinyl Estradiol—prostate cancer	0.000986	0.0781	CbGdCrCtD
Fludarabine—S-Adenosylmethionine—COMT—prostate cancer	0.000944	0.0645	CrCbGaD
Fludarabine—DCK—Levorphanol—Estrone—prostate cancer	0.00094	0.0745	CbGdCrCtD
Fludarabine—Adenosine monophosphate—PDE4D—prostate cancer	0.000919	0.0628	CrCbGaD
Fludarabine—POLA1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000818	0.0648	CbGdCrCtD
Fludarabine—Adenosine triphosphate—AKT1—prostate cancer	0.000815	0.0557	CrCbGaD
Fludarabine—Adenosine monophosphate—SRC—prostate cancer	0.000804	0.0549	CrCbGaD
Fludarabine—DCK—Levorphanol—Estradiol—prostate cancer	0.000712	0.0564	CbGdCrCtD
Fludarabine—Cytarabine—SLC22A1—prostate cancer	0.000626	0.0428	CrCbGaD
Fludarabine—Cladribine—SLC22A1—prostate cancer	0.000576	0.0394	CrCbGaD
Fludarabine—DCK—Doxorubicin—Epirubicin—prostate cancer	0.000495	0.0392	CbGdCrCtD
Fludarabine—DCK—Epirubicin—Doxorubicin—prostate cancer	0.000458	0.0363	CbGdCrCtD
Fludarabine—S-Adenosylmethionine—CYP2E1—prostate cancer	0.00044	0.03	CrCbGaD
Fludarabine—DCK—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000337	0.0267	CbGdCrCtD
Fludarabine—RRM1—Metabolism—HSD17B3—prostate cancer	0.000228	0.000965	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—MYC—prostate cancer	0.000228	0.000965	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	0.000226	0.000957	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—HIST1H4H—prostate cancer	0.000225	0.000956	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	0.000225	0.000955	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000225	0.000953	CbGpPWpGaD
Fludarabine—POLA1—DNA Replication—CDKN1B—prostate cancer	0.000224	0.00095	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—prostate cancer	0.000222	0.000941	CbGpPWpGaD
Fludarabine—POLA1—Synthesis of DNA—CDKN1A—prostate cancer	0.00022	0.000935	CbGpPWpGaD
Fludarabine—Cytarabine—CYP3A4—prostate cancer	0.000219	0.0149	CrCbGaD
Fludarabine—RRM1—Metabolism—ARG2—prostate cancer	0.000218	0.000926	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—UMPS—prostate cancer	0.000218	0.000926	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PHGDH—prostate cancer	0.000218	0.000926	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—CDKN1B—prostate cancer	0.000216	0.000915	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	0.000215	0.000911	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—LDHB—prostate cancer	0.000214	0.000908	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MAD1L1—prostate cancer	0.000212	0.000899	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP3A5—prostate cancer	0.00021	0.000891	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	0.000209	0.000886	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—HIST1H2BG—prostate cancer	0.000209	0.000885	CbGpPWpGaD
Fludarabine—POLA1—DNA Replication—CDKN1A—prostate cancer	0.000207	0.000877	CbGpPWpGaD
Fludarabine—DCK—Metabolism—B4GALT4—prostate cancer	0.000206	0.000874	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HPGD—prostate cancer	0.000206	0.000874	CbGpPWpGaD
Fludarabine—Dyspnoea—Etoposide—prostate cancer	0.000205	0.000357	CcSEcCtD
Fludarabine—Alopecia—Prednisone—prostate cancer	0.000205	0.000357	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	0.000204	0.000867	CbGpPWpGaD
Fludarabine—Hyperglycaemia—Epirubicin—prostate cancer	0.000204	0.000356	CcSEcCtD
Fludarabine—Malaise—Capecitabine—prostate cancer	0.000204	0.000356	CcSEcCtD
Fludarabine—Cough—Docetaxel—prostate cancer	0.000204	0.000356	CcSEcCtD
Fludarabine—Angina pectoris—Doxorubicin—prostate cancer	0.000204	0.000355	CcSEcCtD
Fludarabine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000204	0.000354	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	0.000203	0.000863	CbGpPWpGaD
Fludarabine—Pneumonia—Epirubicin—prostate cancer	0.000203	0.000354	CcSEcCtD
Fludarabine—RRM1—Metabolism—PDHA1—prostate cancer	0.000203	0.00086	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—TCN2—prostate cancer	0.000203	0.00086	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTA3—prostate cancer	0.000203	0.00086	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—UCP3—prostate cancer	0.000203	0.00086	CbGpPWpGaD
Fludarabine—Diarrhoea—Estradiol—prostate cancer	0.000203	0.000353	CcSEcCtD
Fludarabine—Leukopenia—Capecitabine—prostate cancer	0.000203	0.000353	CcSEcCtD
Fludarabine—Convulsion—Docetaxel—prostate cancer	0.000203	0.000353	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	0.000203	0.00086	CbGpPWpGaD
Fludarabine—DCK—Desoximetasone—Prednisone—prostate cancer	0.000203	0.0161	CbGdCrCtD
Fludarabine—Malnutrition—Prednisone—prostate cancer	0.000202	0.000351	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—HIST1H4H—prostate cancer	0.000202	0.000855	CbGpPWpGaD
Fludarabine—Bronchitis—Doxorubicin—prostate cancer	0.000202	0.000351	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.0002	0.000349	CcSEcCtD
Fludarabine—Decreased appetite—Etoposide—prostate cancer	0.0002	0.000348	CcSEcCtD
Fludarabine—Arthralgia—Docetaxel—prostate cancer	0.000199	0.000347	CcSEcCtD
Fludarabine—Myalgia—Docetaxel—prostate cancer	0.000199	0.000347	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—CDKN1A—prostate cancer	0.000199	0.000845	CbGpPWpGaD
Fludarabine—Pancytopenia—Doxorubicin—prostate cancer	0.000199	0.000347	CcSEcCtD
Fludarabine—Renal failure—Epirubicin—prostate cancer	0.000199	0.000346	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000199	0.000842	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Etoposide—prostate cancer	0.000198	0.000345	CcSEcCtD
Fludarabine—Asthenia—Mitoxantrone—prostate cancer	0.000198	0.000345	CcSEcCtD
Fludarabine—Fatigue—Etoposide—prostate cancer	0.000198	0.000345	CcSEcCtD
Fludarabine—Neuropathy peripheral—Epirubicin—prostate cancer	0.000198	0.000345	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	0.000198	0.000839	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—prostate cancer	0.000198	0.000839	CbGpPWpGaD
Fludarabine—Cough—Capecitabine—prostate cancer	0.000198	0.000344	CcSEcCtD
Fludarabine—Stomatitis—Epirubicin—prostate cancer	0.000197	0.000343	CcSEcCtD
Fludarabine—DCK—Diflorasone—Prednisone—prostate cancer	0.000197	0.0156	CbGdCrCtD
Fludarabine—Constipation—Etoposide—prostate cancer	0.000197	0.000342	CcSEcCtD
Fludarabine—Pain—Etoposide—prostate cancer	0.000197	0.000342	CcSEcCtD
Fludarabine—Urinary tract infection—Epirubicin—prostate cancer	0.000196	0.000342	CcSEcCtD
Fludarabine—Dysuria—Doxorubicin—prostate cancer	0.000196	0.000341	CcSEcCtD
Fludarabine—Neutropenia—Doxorubicin—prostate cancer	0.000196	0.000341	CcSEcCtD
Fludarabine—POLA1—S Phase—CDKN1B—prostate cancer	0.000196	0.000831	CbGpPWpGaD
Fludarabine—Upper respiratory tract infection—Doxorubicin—prostate cancer	0.000195	0.000339	CcSEcCtD
Fludarabine—DCK—Metabolism—TNFRSF21—prostate cancer	0.000194	0.000821	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HSD3B1—prostate cancer	0.000194	0.000821	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SLC22A3—prostate cancer	0.000194	0.000821	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000193	0.000821	CbGpPWpGaD
Fludarabine—Myalgia—Capecitabine—prostate cancer	0.000193	0.000336	CcSEcCtD
Fludarabine—Arthralgia—Capecitabine—prostate cancer	0.000193	0.000336	CcSEcCtD
Fludarabine—Haematuria—Epirubicin—prostate cancer	0.000193	0.000335	CcSEcCtD
Fludarabine—Confusional state—Docetaxel—prostate cancer	0.000193	0.000335	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	0.000192	0.000813	CbGpPWpGaD
Fludarabine—Anaphylactic shock—Docetaxel—prostate cancer	0.000191	0.000332	CcSEcCtD
Fludarabine—Oedema—Docetaxel—prostate cancer	0.000191	0.000332	CcSEcCtD
Fludarabine—Discomfort—Capecitabine—prostate cancer	0.000191	0.000332	CcSEcCtD
Fludarabine—Epistaxis—Epirubicin—prostate cancer	0.000191	0.000332	CcSEcCtD
Fludarabine—Infection—Docetaxel—prostate cancer	0.00019	0.00033	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—MAD1L1—prostate cancer	0.00019	0.000804	CbGpPWpGaD
Fludarabine—Sinusitis—Epirubicin—prostate cancer	0.000189	0.00033	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	0.000189	0.000803	CbGpPWpGaD
Fludarabine—Feeling abnormal—Etoposide—prostate cancer	0.000189	0.00033	CcSEcCtD
Fludarabine—Hyperglycaemia—Doxorubicin—prostate cancer	0.000189	0.000329	CcSEcCtD
Fludarabine—Diarrhoea—Mitoxantrone—prostate cancer	0.000189	0.000329	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000189	0.000801	CbGpPWpGaD
Fludarabine—Vomiting—Estradiol—prostate cancer	0.000189	0.000328	CcSEcCtD
Fludarabine—DCK—Metabolism—CYP7B1—prostate cancer	0.000188	0.000799	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MTAP—prostate cancer	0.000188	0.000799	CbGpPWpGaD
Fludarabine—Pneumonia—Doxorubicin—prostate cancer	0.000188	0.000327	CcSEcCtD
Fludarabine—Nervous system disorder—Docetaxel—prostate cancer	0.000187	0.000326	CcSEcCtD
Fludarabine—Ill-defined disorder—Prednisone—prostate cancer	0.000187	0.000326	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	0.000187	0.000794	CbGpPWpGaD
Fludarabine—Thrombocytopenia—Docetaxel—prostate cancer	0.000187	0.000326	CcSEcCtD
Fludarabine—Rash—Estradiol—prostate cancer	0.000187	0.000325	CcSEcCtD
Fludarabine—POLA1—S Phase—CCND1—prostate cancer	0.000187	0.000793	CbGpPWpGaD
Fludarabine—Dermatitis—Estradiol—prostate cancer	0.000187	0.000325	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	0.000187	0.000792	CbGpPWpGaD
Fludarabine—Anaemia—Prednisone—prostate cancer	0.000187	0.000325	CcSEcCtD
Fludarabine—Confusional state—Capecitabine—prostate cancer	0.000186	0.000325	CcSEcCtD
Fludarabine—Headache—Estradiol—prostate cancer	0.000186	0.000323	CcSEcCtD
Fludarabine—RRM1—Metabolism—TBXAS1—prostate cancer	0.000186	0.000787	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTA4—prostate cancer	0.000186	0.000787	CbGpPWpGaD
Fludarabine—Agitation—Prednisone—prostate cancer	0.000185	0.000323	CcSEcCtD
Fludarabine—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000185	0.000323	CcSEcCtD
Fludarabine—Oedema—Capecitabine—prostate cancer	0.000185	0.000322	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—TOP2A—prostate cancer	0.000184	0.000779	CbGpPWpGaD
Fludarabine—Renal failure—Doxorubicin—prostate cancer	0.000184	0.00032	CcSEcCtD
Fludarabine—Infection—Capecitabine—prostate cancer	0.000184	0.00032	CcSEcCtD
Fludarabine—DCK—Metabolism—SULT1E1—prostate cancer	0.000184	0.000779	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SRD5A1—prostate cancer	0.000184	0.000779	CbGpPWpGaD
Fludarabine—Neuropathy peripheral—Doxorubicin—prostate cancer	0.000183	0.000319	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	0.000183	0.000776	CbGpPWpGaD
Fludarabine—Haemoglobin—Epirubicin—prostate cancer	0.000182	0.000317	CcSEcCtD
Fludarabine—Stomatitis—Doxorubicin—prostate cancer	0.000182	0.000317	CcSEcCtD
Fludarabine—Anorexia—Docetaxel—prostate cancer	0.000182	0.000317	CcSEcCtD
Fludarabine—Malaise—Prednisone—prostate cancer	0.000182	0.000317	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—prostate cancer	0.000182	0.000771	CbGpPWpGaD
Fludarabine—Body temperature increased—Etoposide—prostate cancer	0.000182	0.000316	CcSEcCtD
Fludarabine—Urinary tract infection—Doxorubicin—prostate cancer	0.000182	0.000316	CcSEcCtD
Fludarabine—Nervous system disorder—Capecitabine—prostate cancer	0.000181	0.000316	CcSEcCtD
Fludarabine—Haemorrhage—Epirubicin—prostate cancer	0.000181	0.000316	CcSEcCtD
Fludarabine—Thrombocytopenia—Capecitabine—prostate cancer	0.000181	0.000315	CcSEcCtD
Fludarabine—RRM1—Metabolism—GSTA2—prostate cancer	0.000181	0.000767	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CDKN1A—prostate cancer	0.000181	0.000767	CbGpPWpGaD
Fludarabine—Hypoaesthesia—Epirubicin—prostate cancer	0.00018	0.000314	CcSEcCtD
Fludarabine—Pharyngitis—Epirubicin—prostate cancer	0.00018	0.000313	CcSEcCtD
Fludarabine—Hyperhidrosis—Capecitabine—prostate cancer	0.000179	0.000311	CcSEcCtD
Fludarabine—RRM1—Metabolism—ABCG5—prostate cancer	0.000179	0.000758	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SULT1A1—prostate cancer	0.000179	0.000758	CbGpPWpGaD
Fludarabine—Haematuria—Doxorubicin—prostate cancer	0.000178	0.00031	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	0.000178	0.000753	CbGpPWpGaD
Fludarabine—Epistaxis—Doxorubicin—prostate cancer	0.000176	0.000307	CcSEcCtD
Fludarabine—Anorexia—Capecitabine—prostate cancer	0.000176	0.000307	CcSEcCtD
Fludarabine—Nausea—Estradiol—prostate cancer	0.000176	0.000307	CcSEcCtD
Fludarabine—Vomiting—Mitoxantrone—prostate cancer	0.000176	0.000306	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	0.000175	0.000744	CbGpPWpGaD
Fludarabine—Sinusitis—Doxorubicin—prostate cancer	0.000175	0.000305	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—AURKA—prostate cancer	0.000175	0.000744	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HSD17B3—prostate cancer	0.000175	0.000743	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ACSL4—prostate cancer	0.000175	0.000743	CbGpPWpGaD
Fludarabine—Convulsion—Prednisone—prostate cancer	0.000175	0.000304	CcSEcCtD
Fludarabine—Visual impairment—Epirubicin—prostate cancer	0.000175	0.000304	CcSEcCtD
Fludarabine—RRM1—Metabolism—GSTA1—prostate cancer	0.000174	0.00074	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—NBN—prostate cancer	0.000174	0.000739	CbGpPWpGaD
Fludarabine—Rash—Mitoxantrone—prostate cancer	0.000174	0.000303	CcSEcCtD
Fludarabine—Dermatitis—Mitoxantrone—prostate cancer	0.000174	0.000303	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000174	0.000303	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CCND1—prostate cancer	0.000174	0.000736	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MLH1—prostate cancer	0.000173	0.000735	CbGpPWpGaD
Fludarabine—Headache—Mitoxantrone—prostate cancer	0.000173	0.000301	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	0.000173	0.000734	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HSD3B2—prostate cancer	0.000173	0.000732	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NAT2—prostate cancer	0.000173	0.000732	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTO1—prostate cancer	0.000173	0.000732	CbGpPWpGaD
Fludarabine—Myalgia—Prednisone—prostate cancer	0.000172	0.000299	CcSEcCtD
Fludarabine—Arthralgia—Prednisone—prostate cancer	0.000172	0.000299	CcSEcCtD
Fludarabine—Paraesthesia—Docetaxel—prostate cancer	0.000171	0.000299	CcSEcCtD
Fludarabine—Erythema multiforme—Epirubicin—prostate cancer	0.000171	0.000298	CcSEcCtD
Fludarabine—Dyspnoea—Docetaxel—prostate cancer	0.00017	0.000296	CcSEcCtD
Fludarabine—Discomfort—Prednisone—prostate cancer	0.00017	0.000296	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	0.00017	0.000719	CbGpPWpGaD
Fludarabine—Hypersensitivity—Etoposide—prostate cancer	0.000169	0.000295	CcSEcCtD
Fludarabine—Haemoglobin—Doxorubicin—prostate cancer	0.000169	0.000294	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000168	0.000293	CcSEcCtD
Fludarabine—Dyspepsia—Docetaxel—prostate cancer	0.000168	0.000293	CcSEcCtD
Fludarabine—DCK—Metabolism—ARG2—prostate cancer	0.000168	0.000712	CbGpPWpGaD
Fludarabine—DCK—Metabolism—UMPS—prostate cancer	0.000168	0.000712	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PHGDH—prostate cancer	0.000168	0.000712	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—prostate cancer	0.000168	0.000712	CbGpPWpGaD
Fludarabine—Haemorrhage—Doxorubicin—prostate cancer	0.000168	0.000292	CcSEcCtD
Fludarabine—Hypoaesthesia—Doxorubicin—prostate cancer	0.000167	0.000291	CcSEcCtD
Fludarabine—Pharyngitis—Doxorubicin—prostate cancer	0.000167	0.00029	CcSEcCtD
Fludarabine—Paraesthesia—Capecitabine—prostate cancer	0.000166	0.000289	CcSEcCtD
Fludarabine—Decreased appetite—Docetaxel—prostate cancer	0.000166	0.000289	CcSEcCtD
Fludarabine—RRM1—Metabolism—PLCB2—prostate cancer	0.000165	0.000701	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—LRP2—prostate cancer	0.000165	0.000701	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP2C18—prostate cancer	0.000165	0.000701	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—MYC—prostate cancer	0.000165	0.0007	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000165	0.000287	CcSEcCtD
Fludarabine—Asthenia—Etoposide—prostate cancer	0.000165	0.000287	CcSEcCtD
Fludarabine—Dyspnoea—Capecitabine—prostate cancer	0.000165	0.000287	CcSEcCtD
Fludarabine—Oedema—Prednisone—prostate cancer	0.000165	0.000287	CcSEcCtD
Fludarabine—Anaphylactic shock—Prednisone—prostate cancer	0.000165	0.000287	CcSEcCtD
Fludarabine—DCK—Metabolism—LDHB—prostate cancer	0.000165	0.000698	CbGpPWpGaD
Fludarabine—Fatigue—Docetaxel—prostate cancer	0.000165	0.000287	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—TOP2A—prostate cancer	0.000164	0.000697	CbGpPWpGaD
Fludarabine—Nausea—Mitoxantrone—prostate cancer	0.000164	0.000286	CcSEcCtD
Fludarabine—Infection—Prednisone—prostate cancer	0.000164	0.000285	CcSEcCtD
Fludarabine—Constipation—Docetaxel—prostate cancer	0.000163	0.000284	CcSEcCtD
Fludarabine—Pain—Docetaxel—prostate cancer	0.000163	0.000284	CcSEcCtD
Fludarabine—Dyspepsia—Capecitabine—prostate cancer	0.000163	0.000283	CcSEcCtD
Fludarabine—Chills—Epirubicin—prostate cancer	0.000163	0.000283	CcSEcCtD
Fludarabine—Pruritus—Etoposide—prostate cancer	0.000163	0.000283	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—prostate cancer	0.000162	0.000689	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—P4HB—prostate cancer	0.000162	0.000688	CbGpPWpGaD
Fludarabine—Arrhythmia—Epirubicin—prostate cancer	0.000162	0.000282	CcSEcCtD
Fludarabine—Visual impairment—Doxorubicin—prostate cancer	0.000162	0.000281	CcSEcCtD
Fludarabine—DCK—Metabolism—CYP3A5—prostate cancer	0.000162	0.000686	CbGpPWpGaD
Fludarabine—Nervous system disorder—Prednisone—prostate cancer	0.000162	0.000281	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	0.000161	0.000684	CbGpPWpGaD
Fludarabine—Decreased appetite—Capecitabine—prostate cancer	0.000161	0.00028	CcSEcCtD
Fludarabine—Alopecia—Epirubicin—prostate cancer	0.00016	0.000279	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Capecitabine—prostate cancer	0.00016	0.000278	CcSEcCtD
Fludarabine—Fatigue—Capecitabine—prostate cancer	0.000159	0.000278	CcSEcCtD
Fludarabine—Hyperhidrosis—Prednisone—prostate cancer	0.000159	0.000277	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	0.000159	0.000674	CbGpPWpGaD
Fludarabine—Erythema multiforme—Doxorubicin—prostate cancer	0.000159	0.000276	CcSEcCtD
Fludarabine—Constipation—Capecitabine—prostate cancer	0.000158	0.000275	CcSEcCtD
Fludarabine—Pain—Capecitabine—prostate cancer	0.000158	0.000275	CcSEcCtD
Fludarabine—Malnutrition—Epirubicin—prostate cancer	0.000158	0.000275	CcSEcCtD
Fludarabine—RRM1—Metabolism—SLC22A1—prostate cancer	0.000158	0.000669	CbGpPWpGaD
Fludarabine—Feeling abnormal—Docetaxel—prostate cancer	0.000157	0.000274	CcSEcCtD
Fludarabine—Diarrhoea—Etoposide—prostate cancer	0.000157	0.000274	CcSEcCtD
Fludarabine—Anorexia—Prednisone—prostate cancer	0.000157	0.000273	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—AURKA—prostate cancer	0.000157	0.000665	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PDHA1—prostate cancer	0.000156	0.000662	CbGpPWpGaD
Fludarabine—DCK—Metabolism—UCP3—prostate cancer	0.000156	0.000662	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTA3—prostate cancer	0.000156	0.000662	CbGpPWpGaD
Fludarabine—DCK—Metabolism—TCN2—prostate cancer	0.000156	0.000662	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SULT2A1—prostate cancer	0.000154	0.000652	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	0.000154	0.000652	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000154	0.000652	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	0.000153	0.000649	CbGpPWpGaD
Fludarabine—Feeling abnormal—Capecitabine—prostate cancer	0.000152	0.000265	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—APEX1—prostate cancer	0.000152	0.000646	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—MED12—prostate cancer	0.000151	0.000642	CbGpPWpGaD
Fludarabine—Body temperature increased—Docetaxel—prostate cancer	0.000151	0.000263	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	0.000151	0.00064	CbGpPWpGaD
Fludarabine—Chills—Doxorubicin—prostate cancer	0.000151	0.000262	CcSEcCtD
Fludarabine—RRM1—Metabolism—GNG5—prostate cancer	0.00015	0.000636	CbGpPWpGaD
Fludarabine—Musculoskeletal discomfort—Prednisone—prostate cancer	0.00015	0.000261	CcSEcCtD
Fludarabine—POLA1—S Phase—MYC—prostate cancer	0.00015	0.000636	CbGpPWpGaD
Fludarabine—Arrhythmia—Doxorubicin—prostate cancer	0.00015	0.000261	CcSEcCtD
Fludarabine—DCK—Metabolism—SLC22A3—prostate cancer	0.000149	0.000632	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HSD3B1—prostate cancer	0.000149	0.000632	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	0.000149	0.000631	CbGpPWpGaD
Fludarabine—Alopecia—Doxorubicin—prostate cancer	0.000148	0.000258	CcSEcCtD
Fludarabine—Paraesthesia—Prednisone—prostate cancer	0.000148	0.000257	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCND2—prostate cancer	0.000147	0.000623	CbGpPWpGaD
Fludarabine—Ill-defined disorder—Epirubicin—prostate cancer	0.000146	0.000255	CcSEcCtD
Fludarabine—Body temperature increased—Capecitabine—prostate cancer	0.000146	0.000254	CcSEcCtD
Fludarabine—Vomiting—Etoposide—prostate cancer	0.000146	0.000254	CcSEcCtD
Fludarabine—Malnutrition—Doxorubicin—prostate cancer	0.000146	0.000254	CcSEcCtD
Fludarabine—Anaemia—Epirubicin—prostate cancer	0.000146	0.000254	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	0.000145	0.000617	CbGpPWpGaD
Fludarabine—Agitation—Epirubicin—prostate cancer	0.000145	0.000253	CcSEcCtD
Fludarabine—Dyspepsia—Prednisone—prostate cancer	0.000145	0.000252	CcSEcCtD
Fludarabine—Rash—Etoposide—prostate cancer	0.000145	0.000252	CcSEcCtD
Fludarabine—Dermatitis—Etoposide—prostate cancer	0.000145	0.000252	CcSEcCtD
Fludarabine—RRM1—Metabolism—NCOA3—prostate cancer	0.000145	0.000613	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000144	0.000612	CbGpPWpGaD
Fludarabine—Headache—Etoposide—prostate cancer	0.000144	0.000251	CcSEcCtD
Fludarabine—Decreased appetite—Prednisone—prostate cancer	0.000143	0.000249	CcSEcCtD
Fludarabine—DCK—Metabolism—TBXAS1—prostate cancer	0.000143	0.000606	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTA4—prostate cancer	0.000143	0.000606	CbGpPWpGaD
Fludarabine—Malaise—Epirubicin—prostate cancer	0.000142	0.000248	CcSEcCtD
Fludarabine—Fatigue—Prednisone—prostate cancer	0.000142	0.000247	CcSEcCtD
Fludarabine—Leukopenia—Epirubicin—prostate cancer	0.000141	0.000246	CcSEcCtD
Fludarabine—Constipation—Prednisone—prostate cancer	0.000141	0.000245	CcSEcCtD
Fludarabine—Hypersensitivity—Docetaxel—prostate cancer	0.000141	0.000245	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—CHEK2—prostate cancer	0.00014	0.000595	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—MYC—prostate cancer	0.000139	0.00059	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTA2—prostate cancer	0.000139	0.00059	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HPGDS—prostate cancer	0.000138	0.000585	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	0.000138	0.000584	CbGpPWpGaD
Fludarabine—Cough—Epirubicin—prostate cancer	0.000138	0.00024	CcSEcCtD
Fludarabine—DCK—Metabolism—SULT1A1—prostate cancer	0.000137	0.000583	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ABCG5—prostate cancer	0.000137	0.000583	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP2C19—prostate cancer	0.000137	0.000581	CbGpPWpGaD
Fludarabine—Asthenia—Docetaxel—prostate cancer	0.000137	0.000239	CcSEcCtD
Fludarabine—Convulsion—Epirubicin—prostate cancer	0.000137	0.000238	CcSEcCtD
Fludarabine—Nausea—Etoposide—prostate cancer	0.000137	0.000238	CcSEcCtD
Fludarabine—Hypersensitivity—Capecitabine—prostate cancer	0.000136	0.000237	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—APEX1—prostate cancer	0.000136	0.000577	CbGpPWpGaD
Fludarabine—Feeling abnormal—Prednisone—prostate cancer	0.000136	0.000236	CcSEcCtD
Fludarabine—Ill-defined disorder—Doxorubicin—prostate cancer	0.000136	0.000236	CcSEcCtD
Fludarabine—Pruritus—Docetaxel—prostate cancer	0.000135	0.000235	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	0.000135	0.000573	CbGpPWpGaD
Fludarabine—Anaemia—Doxorubicin—prostate cancer	0.000135	0.000235	CcSEcCtD
Fludarabine—Arthralgia—Epirubicin—prostate cancer	0.000134	0.000234	CcSEcCtD
Fludarabine—Myalgia—Epirubicin—prostate cancer	0.000134	0.000234	CcSEcCtD
Fludarabine—DCK—Metabolism—GSTA1—prostate cancer	0.000134	0.000569	CbGpPWpGaD
Fludarabine—Agitation—Doxorubicin—prostate cancer	0.000134	0.000234	CcSEcCtD
Fludarabine—RRM1—Metabolism—ACHE—prostate cancer	0.000134	0.000567	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTT1—prostate cancer	0.000134	0.000567	CbGpPWpGaD
Fludarabine—Discomfort—Epirubicin—prostate cancer	0.000133	0.000231	CcSEcCtD
Fludarabine—DCK—Metabolism—GSTO1—prostate cancer	0.000133	0.000563	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NAT2—prostate cancer	0.000133	0.000563	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HSD3B2—prostate cancer	0.000133	0.000563	CbGpPWpGaD
Fludarabine—Asthenia—Capecitabine—prostate cancer	0.000133	0.000231	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP2A6—prostate cancer	0.000132	0.000561	CbGpPWpGaD
Fludarabine—Malaise—Doxorubicin—prostate cancer	0.000132	0.000229	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	0.000131	0.000557	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—BRCA1—prostate cancer	0.000131	0.000557	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CCND2—prostate cancer	0.000131	0.000557	CbGpPWpGaD
Fludarabine—Pruritus—Capecitabine—prostate cancer	0.000131	0.000228	CcSEcCtD
Fludarabine—Leukopenia—Doxorubicin—prostate cancer	0.000131	0.000228	CcSEcCtD
Fludarabine—Diarrhoea—Docetaxel—prostate cancer	0.000131	0.000227	CcSEcCtD
Fludarabine—Body temperature increased—Prednisone—prostate cancer	0.00013	0.000227	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	0.00013	0.000552	CbGpPWpGaD
Fludarabine—Confusional state—Epirubicin—prostate cancer	0.00013	0.000226	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	0.00013	0.000551	CbGpPWpGaD
Fludarabine—Anaphylactic shock—Epirubicin—prostate cancer	0.000129	0.000224	CcSEcCtD
Fludarabine—Oedema—Epirubicin—prostate cancer	0.000129	0.000224	CcSEcCtD
Fludarabine—RRM1—Metabolism—AKR1C3—prostate cancer	0.000129	0.000545	CbGpPWpGaD
Fludarabine—Infection—Epirubicin—prostate cancer	0.000128	0.000223	CcSEcCtD
Fludarabine—RRM1—Metabolism—PRKACB—prostate cancer	0.000128	0.000543	CbGpPWpGaD
Fludarabine—Cough—Doxorubicin—prostate cancer	0.000127	0.000222	CcSEcCtD
Fludarabine—DCK—Metabolism—PLCB2—prostate cancer	0.000127	0.00054	CbGpPWpGaD
Fludarabine—DCK—Metabolism—LRP2—prostate cancer	0.000127	0.00054	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP2C18—prostate cancer	0.000127	0.00054	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	0.000127	0.000539	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	0.000127	0.000538	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP17A1—prostate cancer	0.000127	0.000537	CbGpPWpGaD
Fludarabine—Convulsion—Doxorubicin—prostate cancer	0.000127	0.00022	CcSEcCtD
Fludarabine—Diarrhoea—Capecitabine—prostate cancer	0.000127	0.00022	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—TYMS—prostate cancer	0.000126	0.000536	CbGpPWpGaD
Fludarabine—Nervous system disorder—Epirubicin—prostate cancer	0.000126	0.00022	CcSEcCtD
Fludarabine—Thrombocytopenia—Epirubicin—prostate cancer	0.000126	0.00022	CcSEcCtD
Fludarabine—DCK—Metabolism—P4HB—prostate cancer	0.000125	0.000529	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Epirubicin—prostate cancer	0.000125	0.000217	CcSEcCtD
Fludarabine—Arthralgia—Doxorubicin—prostate cancer	0.000124	0.000216	CcSEcCtD
Fludarabine—Myalgia—Doxorubicin—prostate cancer	0.000124	0.000216	CcSEcCtD
Fludarabine—Discomfort—Doxorubicin—prostate cancer	0.000123	0.000214	CcSEcCtD
Fludarabine—Anorexia—Epirubicin—prostate cancer	0.000123	0.000214	CcSEcCtD
Fludarabine—Vomiting—Docetaxel—prostate cancer	0.000121	0.000211	CcSEcCtD
Fludarabine—DCK—Metabolism—SLC22A1—prostate cancer	0.000121	0.000515	CbGpPWpGaD
Fludarabine—Hypersensitivity—Prednisone—prostate cancer	0.000121	0.000211	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	0.000121	0.000513	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NCOA2—prostate cancer	0.000121	0.000512	CbGpPWpGaD
Fludarabine—Rash—Docetaxel—prostate cancer	0.00012	0.00021	CcSEcCtD
Fludarabine—Dermatitis—Docetaxel—prostate cancer	0.00012	0.000209	CcSEcCtD
Fludarabine—Confusional state—Doxorubicin—prostate cancer	0.00012	0.000209	CcSEcCtD
Fludarabine—Headache—Docetaxel—prostate cancer	0.00012	0.000208	CcSEcCtD
Fludarabine—Oedema—Doxorubicin—prostate cancer	0.000119	0.000208	CcSEcCtD
Fludarabine—Anaphylactic shock—Doxorubicin—prostate cancer	0.000119	0.000208	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—BRCA2—prostate cancer	0.000119	0.000504	CbGpPWpGaD
Fludarabine—Infection—Doxorubicin—prostate cancer	0.000118	0.000206	CcSEcCtD
Fludarabine—DCK—Metabolism—SULT2A1—prostate cancer	0.000118	0.000502	CbGpPWpGaD
Fludarabine—Asthenia—Prednisone—prostate cancer	0.000118	0.000206	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	0.000118	0.000499	CbGpPWpGaD
Fludarabine—Vomiting—Capecitabine—prostate cancer	0.000118	0.000205	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000117	0.000204	CcSEcCtD
Fludarabine—Nervous system disorder—Doxorubicin—prostate cancer	0.000117	0.000204	CcSEcCtD
Fludarabine—Thrombocytopenia—Doxorubicin—prostate cancer	0.000117	0.000203	CcSEcCtD
Fludarabine—Rash—Capecitabine—prostate cancer	0.000117	0.000203	CcSEcCtD
Fludarabine—Pruritus—Prednisone—prostate cancer	0.000117	0.000203	CcSEcCtD
Fludarabine—Dermatitis—Capecitabine—prostate cancer	0.000116	0.000203	CcSEcCtD
Fludarabine—DCK—Metabolism—MED12—prostate cancer	0.000116	0.000494	CbGpPWpGaD
Fludarabine—Headache—Capecitabine—prostate cancer	0.000116	0.000202	CcSEcCtD
Fludarabine—Paraesthesia—Epirubicin—prostate cancer	0.000116	0.000201	CcSEcCtD
Fludarabine—DCK—Metabolism—GNG5—prostate cancer	0.000115	0.00049	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Doxorubicin—prostate cancer	0.000115	0.000201	CcSEcCtD
Fludarabine—RRM1—Metabolism—SLC5A5—prostate cancer	0.000115	0.000488	CbGpPWpGaD
Fludarabine—Dyspnoea—Epirubicin—prostate cancer	0.000115	0.0002	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	0.000115	0.000486	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000115	0.000486	CbGpPWpGaD
Fludarabine—Anorexia—Doxorubicin—prostate cancer	0.000114	0.000198	CcSEcCtD
Fludarabine—Nausea—Docetaxel—prostate cancer	0.000113	0.000197	CcSEcCtD
Fludarabine—Dyspepsia—Epirubicin—prostate cancer	0.000113	0.000197	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—TYMS—prostate cancer	0.000113	0.000479	CbGpPWpGaD
Fludarabine—Diarrhoea—Prednisone—prostate cancer	0.000113	0.000196	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP2E1—prostate cancer	0.000112	0.000477	CbGpPWpGaD
Fludarabine—Decreased appetite—Epirubicin—prostate cancer	0.000112	0.000195	CcSEcCtD
Fludarabine—DCK—Metabolism—NCOA3—prostate cancer	0.000111	0.000472	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000111	0.000194	CcSEcCtD
Fludarabine—RRM1—Metabolism—NQO1—prostate cancer	0.000111	0.000471	CbGpPWpGaD
Fludarabine—Fatigue—Epirubicin—prostate cancer	0.000111	0.000193	CcSEcCtD
Fludarabine—Constipation—Epirubicin—prostate cancer	0.00011	0.000192	CcSEcCtD
Fludarabine—Pain—Epirubicin—prostate cancer	0.00011	0.000192	CcSEcCtD
Fludarabine—Nausea—Capecitabine—prostate cancer	0.00011	0.000191	CcSEcCtD
Fludarabine—RRM1—Metabolism—TH—prostate cancer	0.00011	0.000465	CbGpPWpGaD
Fludarabine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000109	0.000189	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP3A4—prostate cancer	0.000108	0.00046	CbGpPWpGaD
Fludarabine—Paraesthesia—Doxorubicin—prostate cancer	0.000107	0.000186	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP1B1—prostate cancer	0.000107	0.000452	CbGpPWpGaD
Fludarabine—Dyspnoea—Doxorubicin—prostate cancer	0.000106	0.000185	CcSEcCtD
Fludarabine—Feeling abnormal—Epirubicin—prostate cancer	0.000106	0.000185	CcSEcCtD
Fludarabine—DCK—Metabolism—HPGDS—prostate cancer	0.000106	0.00045	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP2C19—prostate cancer	0.000105	0.000447	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	0.000105	0.000447	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	0.000105	0.000446	CbGpPWpGaD
Fludarabine—Dyspepsia—Doxorubicin—prostate cancer	0.000105	0.000183	CcSEcCtD
Fludarabine—Vomiting—Prednisone—prostate cancer	0.000105	0.000182	CcSEcCtD
Fludarabine—Rash—Prednisone—prostate cancer	0.000104	0.000181	CcSEcCtD
Fludarabine—Dermatitis—Prednisone—prostate cancer	0.000104	0.000181	CcSEcCtD
Fludarabine—Decreased appetite—Doxorubicin—prostate cancer	0.000104	0.00018	CcSEcCtD
Fludarabine—RRM1—Metabolism—GGT1—prostate cancer	0.000103	0.000438	CbGpPWpGaD
Fludarabine—Headache—Prednisone—prostate cancer	0.000103	0.00018	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	0.000103	0.000437	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ACHE—prostate cancer	0.000103	0.000437	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTT1—prostate cancer	0.000103	0.000437	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.000103	0.000179	CcSEcCtD
Fludarabine—Fatigue—Doxorubicin—prostate cancer	0.000103	0.000179	CcSEcCtD
Fludarabine—Constipation—Doxorubicin—prostate cancer	0.000102	0.000177	CcSEcCtD
Fludarabine—Pain—Doxorubicin—prostate cancer	0.000102	0.000177	CcSEcCtD
Fludarabine—Body temperature increased—Epirubicin—prostate cancer	0.000102	0.000177	CcSEcCtD
Fludarabine—DCK—Metabolism—CYP2A6—prostate cancer	0.000102	0.000432	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NCOA1—prostate cancer	0.000102	0.000431	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CYP19A1—prostate cancer	0.0001	0.000425	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AKR1C3—prostate cancer	9.9e-05	0.00042	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PRKACB—prostate cancer	9.85e-05	0.000418	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TERT—prostate cancer	9.84e-05	0.000417	CbGpPWpGaD
Fludarabine—Feeling abnormal—Doxorubicin—prostate cancer	9.82e-05	0.000171	CcSEcCtD
Fludarabine—Nausea—Prednisone—prostate cancer	9.78e-05	0.00017	CcSEcCtD
Fludarabine—DCK—Metabolism—CYP17A1—prostate cancer	9.74e-05	0.000413	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	9.74e-05	0.000413	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—RXRA—prostate cancer	9.67e-05	0.00041	CbGpPWpGaD
Fludarabine—Hypersensitivity—Epirubicin—prostate cancer	9.49e-05	0.000165	CcSEcCtD
Fludarabine—Body temperature increased—Doxorubicin—prostate cancer	9.42e-05	0.000164	CcSEcCtD
Fludarabine—RRM1—Metabolism—COMT—prostate cancer	9.32e-05	0.000395	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NCOA2—prostate cancer	9.28e-05	0.000394	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTP1—prostate cancer	9.27e-05	0.000393	CbGpPWpGaD
Fludarabine—Asthenia—Epirubicin—prostate cancer	9.24e-05	0.000161	CcSEcCtD
Fludarabine—RRM1—Metabolism—ITPR1—prostate cancer	9.12e-05	0.000387	CbGpPWpGaD
Fludarabine—Pruritus—Epirubicin—prostate cancer	9.11e-05	0.000159	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	8.95e-05	0.00038	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SLC5A5—prostate cancer	8.86e-05	0.000376	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—ATM—prostate cancer	8.85e-05	0.000375	CbGpPWpGaD
Fludarabine—Diarrhoea—Epirubicin—prostate cancer	8.81e-05	0.000153	CcSEcCtD
Fludarabine—Hypersensitivity—Doxorubicin—prostate cancer	8.78e-05	0.000153	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	8.66e-05	0.000367	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP2E1—prostate cancer	8.65e-05	0.000367	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—TYMS—prostate cancer	8.62e-05	0.000366	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NQO1—prostate cancer	8.55e-05	0.000363	CbGpPWpGaD
Fludarabine—Asthenia—Doxorubicin—prostate cancer	8.55e-05	0.000149	CcSEcCtD
Fludarabine—RRM1—Metabolism—GSTM1—prostate cancer	8.52e-05	0.000361	CbGpPWpGaD
Fludarabine—Pruritus—Doxorubicin—prostate cancer	8.43e-05	0.000147	CcSEcCtD
Fludarabine—DCK—Metabolism—TH—prostate cancer	8.43e-05	0.000358	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—LPL—prostate cancer	8.36e-05	0.000355	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP3A4—prostate cancer	8.34e-05	0.000354	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP1B1—prostate cancer	8.2e-05	0.000348	CbGpPWpGaD
Fludarabine—Vomiting—Epirubicin—prostate cancer	8.19e-05	0.000143	CcSEcCtD
Fludarabine—Diarrhoea—Doxorubicin—prostate cancer	8.16e-05	0.000142	CcSEcCtD
Fludarabine—Rash—Epirubicin—prostate cancer	8.12e-05	0.000141	CcSEcCtD
Fludarabine—Dermatitis—Epirubicin—prostate cancer	8.11e-05	0.000141	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP1A1—prostate cancer	8.08e-05	0.000343	CbGpPWpGaD
Fludarabine—Headache—Epirubicin—prostate cancer	8.07e-05	0.00014	CcSEcCtD
Fludarabine—RRM1—Metabolism—ERCC2—prostate cancer	8.01e-05	0.00034	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GGT1—prostate cancer	7.94e-05	0.000337	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NCOA1—prostate cancer	7.82e-05	0.000332	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP19A1—prostate cancer	7.71e-05	0.000327	CbGpPWpGaD
Fludarabine—Nausea—Epirubicin—prostate cancer	7.65e-05	0.000133	CcSEcCtD
Fludarabine—Vomiting—Doxorubicin—prostate cancer	7.58e-05	0.000132	CcSEcCtD
Fludarabine—RRM1—Metabolism—MTHFR—prostate cancer	7.53e-05	0.000319	CbGpPWpGaD
Fludarabine—Rash—Doxorubicin—prostate cancer	7.52e-05	0.000131	CcSEcCtD
Fludarabine—Dermatitis—Doxorubicin—prostate cancer	7.51e-05	0.000131	CcSEcCtD
Fludarabine—Headache—Doxorubicin—prostate cancer	7.47e-05	0.00013	CcSEcCtD
Fludarabine—DCK—Metabolism—RXRA—prostate cancer	7.44e-05	0.000316	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPARA—prostate cancer	7.39e-05	0.000313	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	7.31e-05	0.00031	CbGpPWpGaD
Fludarabine—DCK—Metabolism—COMT—prostate cancer	7.17e-05	0.000304	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTP1—prostate cancer	7.13e-05	0.000303	CbGpPWpGaD
Fludarabine—Nausea—Doxorubicin—prostate cancer	7.08e-05	0.000123	CcSEcCtD
Fludarabine—DCK—Metabolism—ITPR1—prostate cancer	7.02e-05	0.000298	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CAV1—prostate cancer	6.95e-05	0.000295	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—prostate cancer	6.67e-05	0.000283	CbGpPWpGaD
Fludarabine—DCK—Metabolism—TYMS—prostate cancer	6.63e-05	0.000281	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTM1—prostate cancer	6.56e-05	0.000278	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MDM2—prostate cancer	6.53e-05	0.000277	CbGpPWpGaD
Fludarabine—DCK—Metabolism—LPL—prostate cancer	6.44e-05	0.000273	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCND1—prostate cancer	6.36e-05	0.00027	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CG—prostate cancer	6.33e-05	0.000268	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP1A1—prostate cancer	6.22e-05	0.000264	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ERCC2—prostate cancer	6.16e-05	0.000261	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—prostate cancer	6.16e-05	0.000261	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—INS—prostate cancer	5.99e-05	0.000254	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN1B—prostate cancer	5.96e-05	0.000253	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CREBBP—prostate cancer	5.87e-05	0.000249	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—EP300—prostate cancer	5.86e-05	0.000248	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MTHFR—prostate cancer	5.79e-05	0.000246	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CCND1—prostate cancer	5.69e-05	0.000241	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PPARA—prostate cancer	5.68e-05	0.000241	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CD—prostate cancer	5.56e-05	0.000236	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN1A—prostate cancer	5.5e-05	0.000233	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CAV1—prostate cancer	5.34e-05	0.000227	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NOS3—prostate cancer	5.25e-05	0.000223	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—EP300—prostate cancer	5.24e-05	0.000222	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MYC—prostate cancer	5.1e-05	0.000216	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CG—prostate cancer	4.87e-05	0.000206	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CB—prostate cancer	4.85e-05	0.000206	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTGS2—prostate cancer	4.8e-05	0.000204	CbGpPWpGaD
Fludarabine—DCK—Metabolism—INS—prostate cancer	4.61e-05	0.000195	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MYC—prostate cancer	4.56e-05	0.000194	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CREBBP—prostate cancer	4.51e-05	0.000191	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CD—prostate cancer	4.28e-05	0.000182	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTEN—prostate cancer	4.19e-05	0.000178	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NOS3—prostate cancer	4.04e-05	0.000171	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—EP300—prostate cancer	3.99e-05	0.000169	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TP53—prostate cancer	3.75e-05	0.000159	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CB—prostate cancer	3.73e-05	0.000158	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTGS2—prostate cancer	3.7e-05	0.000157	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTEN—prostate cancer	3.22e-05	0.000137	CbGpPWpGaD
Fludarabine—DCK—Metabolism—EP300—prostate cancer	3.07e-05	0.00013	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CA—prostate cancer	2.96e-05	0.000125	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AKT1—prostate cancer	2.41e-05	0.000102	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CA—prostate cancer	2.27e-05	9.64e-05	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AKT1—prostate cancer	1.86e-05	7.88e-05	CbGpPWpGaD
